There are 2936 resources available
Overall survival in nmCRPC: Translating recent data into a plan of action
Presenter: Jennifer Sutton
Session: PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?
Resources:
Webcast
Reviewing the latest phase III efficacy data for unresectable HCC
Presenter: Andrew Zhu
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Exploring key safety data for cancer immunotherapy combinations
Presenter: Philippe Merle
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Moving into the clinic: how will these data inform our clinical decisions?
Presenter: Arndt Vogel
Session: F. Hoffmann-La Roche - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:00-15:30
Presenter: George Demetri
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:30-16:00
Presenter: James Larkin
Session: Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
Resources:
Webcast
Live Q&A - 18 September 2020 - 17:00-17:30
Presenter: Emile Voest
Session: F. Hoffmann-La Roche - Putting personalised healthcare at the heart of clinical practice
Resources:
Webcast
Live Q&A - 15 September 2020 - 09:30-10:00
Presenter: Peter R. Galle
Session: Ipsen - The today and tomorrow of systemic treatment for HCC
Resources:
Webcast
An overview of NSCLC
Presenter: Marina Garassino
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Mitigating and managing adverse events associated with androgen receptor-targeted therapies
Presenter: Jennifer Sutton
Session: PeerVoice - Extending overall survival in nmCRPC while maintaining quality of life: Can we have it all?
Resources:
Webcast